{"resourceType":"Parameters","parameter":[{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0410-dose1-evaluation","status":"completed","patient":{"reference":"Patient/2013-0410"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0410-dose1"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0410-dose2-evaluation","status":"completed","patient":{"reference":"Patient/2013-0410"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0410-dose2"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0410-dose3-evaluation","status":"completed","patient":{"reference":"Patient/2013-0410"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0410-dose3"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0410"},"date":"2020-06-29T00:00:00.000","recommendation":[{"targetDisease":[{"coding":[{"system":"http//snomed.info/sct","code":"363354003","display":"Malignant tumour of cervix"},{"system":"http//snomed.info/sct","code":"266113007","display":"Genital warts"}]}],"forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"description":"Evaluation_Test_Type: Age: At Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when a third dose of the HPV vaccine is administered at 24 weeks from dose number 1, that the dose is valid.  The series is complete.","series":"VaccineGroupName.hpv"}]}}]}